Double maintains 2 strategies that include VIR - Vir Biotechnology, Inc.
Current Value
$4.991 Year Return
Current Value
$4.991 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 47.68% | $44.43M | 0.5% |
PBE | 44.38% | $223.24M | 0.58% |
XBI | 43.88% | $4.95B | 0.35% |
FBT | 43.44% | $1.01B | 0.54% |
IBB | 42.96% | $5.36B | 0.45% |
ARKG | 42.49% | $1.05B | 0.75% |
BBH | 38.73% | $329.82M | 0.35% |
IWO | 38.15% | $11.48B | 0.24% |
XHE | 38.05% | $165.61M | 0.35% |
SMLF | 37.73% | $1.81B | 0.15% |
IJT | 37.63% | $6.05B | 0.18% |
VTWO | 37.37% | $13.29B | 0.07% |
PTH | 37.33% | $101.07M | 0.6% |
IWM | 37.30% | $64.00B | 0.19% |
SLYG | 37.28% | $3.39B | 0.15% |
PRFZ | 37.03% | $2.36B | 0.34% |
ISCG | 36.86% | $679.06M | 0.06% |
IJR | 36.81% | $78.78B | 0.06% |
GSSC | 36.81% | $586.95M | 0.2% |
VIOO | 36.75% | $2.86B | 0.1% |
Yahoo
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Finnhub
Presenter SpeechKyuwon Choi Okay. We'll continue with the next session. Good afternoon, everyone. I'm Paul Choi, and I cover biotechnology here at the firm. It's my pleasure to welcome Vir to our
Yahoo
In the last week, the market has been flat, but over the past 12 months, it has risen by 12%, with earnings forecast to grow by 14% annually. While traditional investments often focus on established companies, penny stocks—though an outdated term—still represent smaller or less-established firms that can offer significant value. By honing in on those with robust financials and a clear growth trajectory, investors can uncover promising opportunities among these lesser-known names.
Yahoo
SAN FRANCISCO, May 28, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10 at 1:00 p.m. PT / 4:00 p.m. ET in Miami Beach, Florida.
Yahoo
SAN FRANCISCO, May 20, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, and Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head, Oncology, will participate in a virtual fireside chat at the TD Cowen 6th Annual Oncology Innovation Summit on Tuesday, May 27 at 1:30 p.m. PT / 4:30 p.m. ET.
Finnhub
Presenter SpeechAlec Stranahan Thanks for joining day 2 of the 2025 Bank of America Healthcare Conference. My name is Alec Stranahan. I'm senior biotech analyst covering Vir at Bank of America. And...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -30.65% | $99.76M | 0.59% |
BTAL | -30.17% | $296.79M | 1.43% |
VIXY | -29.12% | $165.69M | 0.85% |
IBMP | -14.15% | $553.29M | 0.18% |
FXY | -12.70% | $815.67M | 0.4% |
IVOL | -11.86% | $349.27M | 1.02% |
CANE | -11.58% | $10.44M | 0.29% |
UDN | -11.31% | $147.88M | 0.78% |
FTSD | -10.19% | $231.79M | 0.25% |
SHYM | -9.84% | $350.04M | 0.35% |
BWX | -9.69% | $1.53B | 0.35% |
BSMW | -9.65% | $107.26M | 0.18% |
CLIP | -9.23% | $1.52B | 0.07% |
UTWO | -9.18% | $379.36M | 0.15% |
IBTI | -9.14% | $1.06B | 0.07% |
MLN | -9.08% | $540.30M | 0.24% |
TPMN | -9.03% | $30.81M | 0.65% |
STXT | -9.02% | $129.73M | 0.49% |
XONE | -8.67% | $585.86M | 0.03% |
SPTS | -8.62% | $5.78B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -12.94% | $23.98B | +34.66% | 1.10% |
CL | -12.72% | $71.89B | -8.58% | 2.28% |
RCEL | -9.02% | $135.39M | -31.19% | 0.00% |
CYCN | -8.99% | $9.63M | +30.43% | 0.00% |
EIX | -8.29% | $19.61B | -29.02% | 6.34% |
KMB | -7.81% | $42.44B | -7.46% | 3.88% |
CME | -7.63% | $99.01B | +39.76% | 3.87% |
BBD | -7.60% | $16.07B | +43.03% | 1.29% |
CWT | -6.88% | $2.71B | -6.14% | 2.55% |
MO | -6.86% | $98.96B | +28.98% | 6.98% |
ADC | -6.75% | $7.96B | +16.81% | 4.20% |
ED | -5.98% | $35.36B | +9.76% | 3.39% |
KR | -5.81% | $47.56B | +43.04% | 1.79% |
AWK | -5.65% | $26.90B | +6.78% | 2.27% |
TU | -5.40% | $24.14B | +4.56% | 7.30% |
K | -5.29% | $27.41B | +36.96% | 2.88% |
SBS | -5.23% | $14.33B | +55.91% | 3.11% |
AQB | -5.14% | $2.84M | -54.35% | 0.00% |
CCRN | -4.75% | $419.30M | -7.59% | 0.00% |
VSTA | -4.44% | $342.46M | +40.00% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SANA | 73.68% | $633.81M | -48.53% | 0.00% |
ANGO | 54.87% | $397.14M | +61.65% | 0.00% |
CPRX | 46.94% | $2.66B | +40.61% | 0.00% |
EBAY | 42.81% | $34.00B | +37.30% | 1.51% |
MATW | 42.50% | $755.37M | -2.75% | 4.09% |
COLL | 39.42% | $962.02M | -7.05% | 0.00% |
AYI | 38.68% | $9.37B | +25.64% | 0.21% |
HALO | 38.48% | $6.43B | -0.29% | 0.00% |
ENOV | 37.38% | $1.82B | -29.69% | 0.00% |
PRLB | 37.38% | $962.23M | +31.05% | 0.00% |
TILE | 37.02% | $1.24B | +43.60% | 0.19% |
SKYW | 36.92% | $4.18B | +25.99% | 0.00% |
MDGL | 36.91% | $6.68B | +7.35% | 0.00% |
WAT | 36.72% | $20.97B | +21.47% | 0.00% |
IQV | 36.45% | $27.24B | -25.53% | 0.00% |
NRIX | 35.92% | $887.38M | -44.23% | 0.00% |
MSM | 35.80% | $4.76B | +7.78% | 3.95% |
AMBA | 35.63% | $2.84B | +24.30% | 0.00% |
BNT | 35.40% | $12.40B | +48.28% | 0.00% |
DNLI | 35.38% | $2.05B | -39.28% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPB | <0.01% | $9.18B | -31.87% | 4.94% |
KO | -0.01% | $302.72B | +10.49% | 2.83% |
QBTS | 0.01% | $4.38B | +1,129.82% | 0.00% |
UGP | -0.02% | $3.33B | -20.72% | 3.87% |
FDP | 0.05% | $1.54B | +46.73% | 3.42% |
IMNN | -0.07% | $15.04M | -36.21% | 0.00% |
VOD | 0.07% | $25.87B | +18.94% | 4.63% |
CCEC | 0.11% | $1.02B | +3.91% | 2.61% |
KRP | 0.13% | $1.30B | -15.04% | 12.27% |
BTI | 0.20% | $102.80B | +51.83% | 8.07% |
MBI | 0.34% | $217.60M | -21.31% | 0.00% |
OXBR | 0.37% | $13.03M | -26.47% | 0.00% |
CAG | 0.44% | $9.74B | -28.22% | 6.87% |
LNT | 0.48% | $15.50B | +18.57% | 3.28% |
EW | 0.48% | $45.88B | -15.33% | 0.00% |
SRRK | 0.51% | $3.40B | +329.89% | 0.00% |
CHD | -0.54% | $23.34B | -8.58% | 1.22% |
PRMB | 0.57% | $11.05B | +38.59% | 1.30% |
POST | -0.58% | $6.06B | +4.39% | 0.00% |
BEEM | -0.60% | $24.22M | -65.94% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BIV | 0.01% | $23.34B | 0.03% |
JPST | 0.03% | $31.84B | 0.18% |
ISTB | -0.04% | $4.45B | 0.06% |
FTSM | 0.09% | $6.40B | 0.45% |
ICSH | -0.14% | $6.02B | 0.08% |
GBIL | 0.15% | $6.38B | 0.12% |
UCON | -0.16% | $2.98B | 0.86% |
BOXX | 0.17% | $6.72B | 0.19% |
MSOS | 0.21% | $302.43M | 0.77% |
HYD | 0.22% | $3.30B | 0.32% |
SCHP | 0.30% | $13.50B | 0.03% |
BILS | 0.30% | $3.86B | 0.1356% |
SHAG | -0.32% | $43.02M | 0.12% |
NEAR | -0.35% | $3.31B | 0.25% |
SPAB | 0.37% | $8.80B | 0.03% |
SCHZ | -0.42% | $8.59B | 0.03% |
CORN | 0.42% | $44.21M | 0.2% |
FIXD | 0.43% | $3.42B | 0.65% |
MBB | -0.45% | $39.34B | 0.04% |
ZROZ | -0.45% | $1.51B | 0.15% |